Herantis Pharma Oyj Share Price Nasdaq Helsinki
Equities
FI4000087861
Biotechnology & Medical Research
Sales 2024 * | 1.3M 1.4M 117M | Sales 2025 * | - | Capitalization | 29.23M 31.48M 2.63B |
---|---|---|---|---|---|
Net income 2024 * | -3M -3.23M -270M | Net income 2025 * | -4M -4.31M -360M | EV / Sales 2024 * | 19.3 x |
Net cash position 2024 * | 4.2M 4.52M 378M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.93% |
Latest transcript on Herantis Pharma Oyj
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 01/08/01 | |
Antti Vuolanto
CEO | Chief Executive Officer | - | 12/18/12 |
Tone Kvåle
DFI | Director of Finance/CFO | 55 | 26/20/26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 01/14/01 | |
Director/Board Member | 53 | 11/20/11 | |
Chairman | 64 | 01/12/01 |
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |